{"entity":{"type":"insider","cik":"0001627362","url":"/insider/0001627362","json_url":"/insider/0001627362.json","name":"Spencer David M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":13,"first":"2015-06-18","last":"2018-09-05","span_basis":"filed_date"},"name_variants":[{"name":"Spencer David M.","source":"filing","n_filings":13,"first_seen":"2015-06-18","last_seen":"2018-09-05"}],"transactions":[{"id":5972162,"accession":"0001358403-18-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-18-000091","line_url":"/filing/0001358403-18-000091#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.0413,"price_display":"7.04","price_state":"stated","total_value":70413.0,"total_display":"70,413.00","shares_owned_after":89939.0,"shares_owned_after_display":"89,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-05","scope":"insider"},{"id":6838752,"accession":"0001358403-18-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-18-000078","line_url":"/filing/0001358403-18-000078#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Technology Officer)","officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":7.6283,"price_display":"7.63","price_state":"stated","total_value":305132.0,"total_display":"305,132.00","shares_owned_after":99939.0,"shares_owned_after_display":"99,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-07-20","scope":"insider"},{"id":4129254,"accession":"0001358403-17-000137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-17-000137","line_url":"/filing/0001358403-17-000137#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.54,"price_display":"11.54","price_state":"stated","total_value":115400.0,"total_display":"115,400.00","shares_owned_after":138965.0,"shares_owned_after_display":"138,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-10","filed_date":"2017-07-12","scope":"insider"},{"id":2078066,"accession":"0001358403-16-000303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000303","line_url":"/filing/0001358403-16-000303#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","shares_owned_after":146082.0,"shares_owned_after_display":"146,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-05","scope":"insider"},{"id":3189371,"accession":"0001358403-16-000300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-16-000300","line_url":"/filing/0001358403-16-000300#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2967.0,"shares_display":"2,967","price_per_share":17.1697,"price_display":"17.17","price_state":"stated","total_value":50942.4999,"total_display":"50,942.50","shares_owned_after":153115.0,"shares_owned_after_display":"153,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":3189369,"accession":"0001358403-16-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000300","line_url":"/filing/0001358403-16-000300#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2033.0,"shares_display":"2,033","price_per_share":18.0432,"price_display":"18.04","price_state":"stated","total_value":36681.8256,"total_display":"36,681.83","shares_owned_after":151082.0,"shares_owned_after_display":"151,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":3267037,"accession":"0001358403-16-000274","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-16-000274","line_url":"/filing/0001358403-16-000274#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6200.0,"shares_display":"6,200","price_per_share":20.1891,"price_display":"20.19","price_state":"stated","total_value":125172.42,"total_display":"125,172.42","shares_owned_after":156082.0,"shares_owned_after_display":"156,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-23","filed_date":"2016-09-23","scope":"insider"},{"id":3267033,"accession":"0001358403-16-000274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-16-000274","line_url":"/filing/0001358403-16-000274#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.6832,"price_display":"19.68","price_state":"stated","total_value":196832.0,"total_display":"196,832.00","shares_owned_after":162282.0,"shares_owned_after_display":"162,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-23","scope":"insider"},{"id":3267027,"accession":"0001358403-16-000274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000274","line_url":"/filing/0001358403-16-000274#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.04,"price_display":"20.04","price_state":"stated","total_value":6012.0,"total_display":"6,012.00","shares_owned_after":172282.0,"shares_owned_after_display":"172,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-21","filed_date":"2016-09-23","scope":"insider"},{"id":2117185,"accession":"0001358403-16-000262","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-16-000262","line_url":"/filing/0001358403-16-000262#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","shares_owned_after":172582.0,"shares_owned_after_display":"172,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-20","scope":"insider"},{"id":2117181,"accession":"0001358403-16-000262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-16-000262","line_url":"/filing/0001358403-16-000262#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":20.0186,"price_display":"20.02","price_state":"stated","total_value":14013.02,"total_display":"14,013.02","shares_owned_after":172682.0,"shares_owned_after_display":"172,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-20","scope":"insider"},{"id":2117178,"accession":"0001358403-16-000262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000262","line_url":"/filing/0001358403-16-000262#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":20.0088,"price_display":"20.01","price_state":"stated","total_value":34014.96,"total_display":"34,014.96","shares_owned_after":173382.0,"shares_owned_after_display":"173,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-20","scope":"insider"},{"id":2220749,"accession":"0001358403-16-000254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000254","line_url":"/filing/0001358403-16-000254#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","shares_owned_after":175082.0,"shares_owned_after_display":"175,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":2685057,"accession":"0001358403-16-000238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-16-000238","line_url":"/filing/0001358403-16-000238#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","shares_owned_after":176082.0,"shares_owned_after_display":"176,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-29","scope":"insider"},{"id":8759648,"accession":"0001358403-15-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-15-000102","line_url":"/filing/0001358403-15-000102#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":22.9478,"price_display":"22.95","price_state":"stated","total_value":114739.0,"total_display":"114,739.00","shares_owned_after":178600.0,"shares_owned_after_display":"178,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8257276,"accession":"0001358403-15-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-15-000075","line_url":"/filing/0001358403-15-000075#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":95000.0,"total_display":"95,000.00","shares_owned_after":178600.0,"shares_owned_after_display":"178,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-15","scope":"insider"},{"id":9284854,"accession":"0001358403-15-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-15-000033","line_url":"/filing/0001358403-15-000033#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17200.0,"shares_display":"17,200","price_per_share":22.8227,"price_display":"22.82","price_state":"stated","total_value":392550.44,"total_display":"392,550.44","shares_owned_after":166400.0,"shares_owned_after_display":"166,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-19","scope":"insider"},{"id":9284853,"accession":"0001358403-15-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-15-000033","line_url":"/filing/0001358403-15-000033#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":23.7939,"price_display":"23.79","price_state":"stated","total_value":66622.92,"total_display":"66,622.92","shares_owned_after":163600.0,"shares_owned_after_display":"163,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-19","scope":"insider"},{"id":8153986,"accession":"0001358403-15-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-15-000020","line_url":"/filing/0001358403-15-000020#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17200.0,"shares_display":"17,200","price_per_share":22.8227,"price_display":"22.82","price_state":"stated","total_value":392550.44,"total_display":"392,550.44","shares_owned_after":165554.0,"shares_owned_after_display":"165,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-18","scope":"insider"},{"id":8153981,"accession":"0001358403-15-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-15-000020","line_url":"/filing/0001358403-15-000020#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001627362","owner_name":"Spencer David M.","owner_url":"/insider/0001627362","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":23.7939,"price_display":"23.79","price_state":"stated","total_value":66622.92,"total_display":"66,622.92","shares_owned_after":162754.0,"shares_owned_after_display":"162,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358403","name":"BELLICUM PHARMACEUTICALS, INC","url":"/issuer/0001358403","role":"Officer (Chief Technology Officer)","n_filings":13,"first_seen":"2015-06-18","last_seen":"2018-09-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001627362","retrieved_at":"2026-08-22T03:15:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}